Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for cis 2
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- Pancreatic cell lines treated with chromatin-targeting small molecules
- Breast cancer MCF-7 cells treated with selective estrogen receptor modulators
Most Relevant Literature
- Cis-2 and trans-2-eisocenoic fatty acids are novel inhibitors for Mycobacterium tuberculosis Protein…
- Janus All-Cis 2,3,4,5,6-Pentafluorocyclohexyl Building Blocks Applied to Medicinal Chemistry and Bio…
- Mast cell regranulation requires a metabolic switch involving mTORC1 and a glucose-6-phosphate trans…
- Evaluating cis-2,6-dimethylpiperidide (cis-DMP) as a base component in lithium-mediated zincation ch…
- hucMSC-Ex alleviates inflammatory bowel disease in mice by enhancing M2-type macrophage polarization…
Most Relevant Clinical Trials
- Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunt…
- Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe A…
- Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
- A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon a…
- Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 …
